Working to Eradicate Gynecologic Cancers

Thomas C. Krivak, MD

Associate Professor
Western Pennsylvania Hospital
4800 Friendship Ave, Suite 508
Pittsburgh, PA
USA 15224

Papers:
41 - Featured Poster The impact and interaction of preoperative disease burden, complex surgery, and residual disease in patients with advanced stage ovarian cancer and the effect on on patient survival: A GOG 182 analysis 46 - Featured Poster Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced-stage serous ovarian or primary peritoneal cancer: a Gynecologic Oncology Group (GOG) study 60 - Scientific Plenary Predictive model for preoperative determination of microscopic residual disease at the time of primary cytoreduction in patients with advanced-stage epithelial ovarian cancer: a Gynecologic Oncology Group (GOG) 182 analysis 84 - Featured Poster Risk factors and impact of refusing recommended therapy in cervical cancer: a National Cancer Data Base (NCDB) study 89 - Featured Poster Characteristics of high-volume gynecologic cancer centers – framework toward centers of excellence: a National Cancer Data Base (NCDB) study 90 - Featured Poster The role of adjuvant radiation and chemoradiation in single node-positive vulvar cancer 237 - Poster Session A Clinicopathologic benchmark for prognostic modeling of advanced epithelial ovarian cancer long-term survival: a Gynecologic Oncology Group (GOG) analysis 263 - Poster Session A BRCA1 mutation determines the impact of profilin1 in ovarian cancer cell motility 433 - Poster Session B Definitive therapy for clinical stage I endometrial cancer in the elderly: a National Cancer Database study 436 - Poster Session B Role of chemosensitization in elderly vaginal cancer patients: a National Cancer Data Base (NCDB) study 490 - Poster Session B The impact of concurrent chemoradiation on survival compared to adjuvant radiation therapy alone in patients with node-positive vulvar cancer